About the project

About

Long Waypoint 3 is an independent information resource focused on ibogaine-related risks, settings, and safeguards. Civic Kiln examines ibogaine as an investigational, medically hazardous intervention and aims to help readers compare care settings, understand screening and monitoring questions, and recognize the limits of available evidence.

Mission — Civic Kiln's mission is to promote independent risk clarity and plain-language guidance for people researching complex, high-risk interventions.

Close-up detail view inside a care setting, illustrating focused clinical equipment and ambient lighting in a therapy centre

Our editorial approach

We collect and summarise publicly available registries, published literature, and official guidance to create concise comparisons of care settings and safety practices. Where relevant, we reference registries and academic summaries to support claims; for example, structured literature reviews on investigational interventions are commonly indexed by academic libraries and repositories such as systematic review summaries on Wikipedia and by university libraries that index clinical trial reporting.

We also link to practitioner registries and treatment directories when they exist to show how services portray themselves; a practical example of how a treatment directory might present facility information can be seen on an industry directory such as ibogaine treatment US listings, which we consult as part of location and setting comparisons.

How information is sourced and vetted

We prioritise primary sources where available: peer-reviewed studies, registries, official clinical guidance, and regulatory advisories. For verification we cross-check claims against reputable reference bodies; for example, clinical safety guidance and regulatory frameworks are often summarised on government health sites such as the U.S. National Library of Medicine (nlm.nih.gov), and that sort of authoritative indexing informs our vetting process.

When information is sparse or contradictory, we state uncertainty clearly and point readers to the underlying documents. Our editorial workflow includes sourcing statements, tagging evidence strength, and flagging unresolved safety concerns rather than offering clinical recommendations.

Who this is for

This resource is intended for people researching ibogaine, their families, and anyone evaluating claims about care settings and safety practices. If you are considering options or supporting someone who is, the materials aim to inform questions to ask and comparisons to make, not to substitute for medical advice.

For readers who want to explore service listings in more depth while they compare protocols, we sometimes include links to directories as contextual reference; for direct examples of facility listings, see the industry directory noted earlier at ibogaine treatment US listings.

Independent by design

Long Waypoint 3 is intentionally structured as an independent editorial resource. We are not a clinic, medical provider, or licensed treatment center; our content does not constitute medical or legal advice. If readers need clinical guidance, they should consult qualified healthcare professionals or official health agencies such as the U.S. Centers for Disease Control and Prevention for general clinical pathways and public-health considerations.

Want to see the site overview? Visit the site front page summary for navigation to core sections about settings, workflows, and comparisons: Explore the site. For service-oriented resources we refer readers to our overview of offerings on the Services page, which explains the types of comparisons and snapshots we maintain.